Traditional Medicare or Medicare Advantage? The leukemia and cancer perspective Review


Authors: Kantarjian, H.; Zeidan, A. M.; Fathi, A. T.; Stein, E.; Rajkumar, V.; Tefferi, A.
Review Title: Traditional Medicare or Medicare Advantage? The leukemia and cancer perspective
Abstract: Today, approximately 50% of patients eligible for Medicare have opted for Medicare Advantage as their primary coverage. Whereas Medicare Advantage is a reasonable option for healthy senior Americans, issues arise once they have serious or chronic medical problems, which are prevalent among older Americans. This review details the pros and cons of standard Medicare vs Medicare Advantage. The authors recommend considering standard Medicare as a better form of insurance coverage. In addition, patients should also enroll in Medicare Part D to get prescription drug coverage; buy a supplemental MediGap policy; and buy additional coverage for hearing, vision, and dental care. Although this is a more complicated process, it is also a better one until Medicare Advantage revises its plans to address the current issues facing Americans on such plans who have serious illnesses. © 2023 Mayo Foundation for Medical Education and Research
Keywords: aged; leukemia; united states; neoplasm; neoplasms; cancer mortality; health insurance; medicare; insurance; vision; short survey; hearing; clinical outcome; insurance coverage; dental procedure; humans; human; insurance, medigap; medicare part c
Journal Title: Mayo Clinic Proceedings
Volume: 99
Issue: 1
ISSN: 0025-6196
Publisher: Mayo Clinic Proceedings  
Date Published: 2024-01-01
Start Page: 15
End Page: 21
Language: English
DOI: 10.1016/j.mayocp.2023.11.004
PUBMED: 38108685
PROVIDER: scopus
DOI/URL:
Notes: Short survey -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Eytan Moshe Stein
    343 Stein